A Study of a New Molecular Approach to Blood DNA Screening for Cancer

Overview

About this study

The primary aim of this study is to evaluate the distribution of marker levels determined by this multi-marker, multi-compartment blood DNA test approach across persons without known cancer or precancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Must be 18 years of age or older
  • Patients without a known internal (non-cutaneous) cancer or a history of an internal cancer

Exclusion Criteria:

  • Present internal cancer (except for melanoma, skin cancer is not an exclusion)
  • History of internal cancer (except for melanoma, skin cancer is not an exclusion)
  • If colonoscopy done in last 5 years:
    • Any colorectal polyps >9mm found
  • A positive Cologuard test at any time
  • Patient has had a transplant
  • Inability to give informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Kisiel, M.D.

Open for enrollment

Contact information:

Karen Doering M.B.A., CCRP

(507) 538-0096

Doering.Karen@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20306514

Mayo Clinic Footer